Contrast-Enhanced Micro-CT Imaging of Cerebral Cavernous Malformation Lesions in a Mouse Brain
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 3:35 min • May 29th, 2025
Loading...
Overview
This article details a method for imaging cerebral cavernous malformations (CCMs) in mouse pup brains using micro-CT. The process involves chemical fixation, staining with iodine, and advanced imaging techniques to visualize abnormal blood vessel formations.
Key Study Components
Area of Science
- Neuroscience
- Imaging Techniques
- Pathology
Background
- Cerebral cavernous malformations are clusters of abnormal blood vessels.
- Understanding CCMs is crucial for insights into vascular malformations in the brain.
- Micro-CT imaging provides high-resolution images of tissue structures.
- Iodine staining enhances contrast in imaging procedures.
Purpose of Study
- To develop a reliable method for visualizing CCMs in mouse models.
- To improve understanding of the pathology associated with CCMs.
- To utilize micro-CT for detailed imaging of brain structures.
Methods Used
- Isolation and fixation of mouse pup brains.
- Staining with iodine to enhance contrast in CCM areas.
- Micro-CT scanning to capture detailed images of the brain.
- 3D reconstruction of images to visualize CCM locations.
Main Results
- Successful imaging of CCMs with enhanced contrast using iodine.
- 3D models generated from micro-CT scans reveal precise locations of CCMs.
- The method allows for detailed analysis of vascular abnormalities in the brain.
- Demonstrated the effectiveness of micro-CT in studying brain pathology.
Conclusions
- The developed imaging technique is effective for studying CCMs.
- This method can aid in further research on vascular malformations.
- Micro-CT imaging provides valuable insights into brain structure and pathology.
Frequently Asked Questions
What are cerebral cavernous malformations?
Cerebral cavernous malformations are clusters of abnormal blood vessels in the brain that can lead to various neurological issues.
How does iodine staining enhance imaging?
Iodine staining increases the contrast of blood vessels in imaging, making abnormalities like CCMs more visible.
What is micro-CT?
Micro-CT is a high-resolution imaging technique that uses X-rays to create detailed 3D images of small structures, such as tissues.
Why is this method important for neuroscience?
This method allows researchers to visualize and study vascular malformations in the brain, contributing to understanding various neurological conditions.
Can this technique be applied to other types of brain abnormalities?
Yes, the imaging technique can be adapted to study other vascular or structural abnormalities in the brain.
Executive Industry Relevance
This method enables non-destructive, high-resolution visualization of vascular malformations in preclinical models, supporting target validation in neurovascular disease research. By providing quantitative 3D lesion mapping, it enhances predictive confidence in early discovery stages where mechanistic clarity is critical for portfolio decisions. The approach facilitates mechanistic de-risking of CCM-related pathways prior to investment in therapeutic development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by visualizing lesion burden and distribution in intact tissue.
- Operational Value: Supports biological de-risking through direct, label-free assessment of vascular abnormality phenotypes.
- Predictive Value: Improves target confidence by correlating structural changes with molecular pathways in disease-relevant systems.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for downstream compound screening by establishing baseline lesion metrics.
- Quantitative Output: Generates reproducible, density-based measurements enabling standardized comparison across experimental conditions.
- Platform Reuse: Establishes a scalable imaging workflow applicable to multiple neurovascular models.
Translational & Preclinical Research
- Disease Relevance: Models human CCM pathology in mouse brains, supporting translational biomarker exploration.
- Preclinical Continuity: Bridges discovery and preclinical validation by providing longitudinal, non-terminal monitoring capability.
- Risk-Adjusted Decisions: Informs advancement criteria through objective, volumetric lesion quantification.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through preclinical evaluation, offering a reusable imaging modality for neurovascular projects.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling direct observation of vascular lesion formation.
- Screening: Delivers assay-ready tissue with standardized contrast enhancement for reliable compound evaluation.
- Analytics: Provides volumetric and density-based readouts that facilitate cross-condition comparison and effect size determination.
- Translational Research: Connects to preclinical validation through consistent, quantifiable lesion metrics across study stages.
- Enterprise Reuse: Functions as a platform capability for multiple CNS vascular pathology projects, reducing redundant method development.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in neurovascular models.
- Operational Value: Ensures standardization and reproducibility through standardized staining and imaging protocols.
- Strategic Value: Improves go/no-go decisions by providing objective, quantifiable lesion data early in the discovery pipeline.
- Portfolio Impact: Enables risk-adjusted prioritization of CCM-targeted projects based on measurable preclinical efficacy signals.
Implementation Considerations
- Requires expertise in histology, tissue preparation, and micro-CT operation.
- Depends on access to micro-CT instrumentation capable of high-resolution soft-tissue imaging.
- Necessitates standardization of staining duration, concentration, and washing steps across laboratories.
- Involves adaptation considerations when applying the protocol to different mouse strains or disease models.
- Limited by tissue size constraints of standard micro-CT systems for whole-brain imaging in adult specimens.
Biopharma FAQs
Why does iodine staining improve lesion detection in CCM models?
Iodine staining enhances X-ray absorption in blood-filled cavernous malformations, increasing contrast between lesions and surrounding brain tissue. This allows for clearer visualization of vascular abnormalities in micro-CT imaging. The improved contrast enables more accurate detection and quantification of CCM lesions in preclinical studies.
How does 3D reconstruction from micro-CT scans support target validation efforts?
3D reconstruction provides spatially resolved mapping of lesion distribution throughout the hindbrain, enabling precise localization of CCMs. This detailed anatomical context helps correlate structural phenotypes with molecular targets under investigation. Such visualization supports mechanistic de-risking by linking target modulation to observable changes in lesion burden.
What quantitative measurements does micro-CT imaging enable for CCM lesion analysis?
Micro-CT imaging generates density-based measurements from iodine-stained lesions, allowing quantification of lesion volume and intensity. These metrics provide objective, reproducible readouts for comparing experimental conditions or genetic models. The quantitative output supports data-driven decision-making in target validation and lead identification stages.
Why are replication requirements important for micro-CT imaging in cross-functional collaboration?
Replication ensures consistent lesion detection and quantification across different operators, laboratories, and time points. Standardized protocols for fixation, staining, and imaging minimize variability that could confound target validation conclusions. Reliable reproducibility is essential for building confidence in preclinical data shared between discovery, translational, and preclinical teams.
What statistical analysis capabilities are needed before implementing micro-CT imaging in a discovery pipeline?
Implementation requires statistical methods capable of analyzing volumetric and density-based lesion data, including group comparisons and correlation with molecular endpoints. Teams need capacity to calculate effect sizes, variance estimates, and statistical power for preclinical study design. These analytical capabilities ensure that imaging outputs can reliably inform go/no-go decisions and portfolio prioritization.
13:10
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Related Videos
0 Views
05:12
A Micro-CT-based Method for Characterizing Lesions and Locating Electrodes in Small Animal Brains
Related Videos
0 Views
07:01
3D Imaging of Soft-Tissue Samples using an X-ray Specific Staining Method and Nanoscopic Computed Tomography
Related Videos
0 Views
05:50
Contrast Enhanced Vessel Imaging using MicroCT
Related Videos
0 Views
06:42
Cerebrovascular Casting of the Adult Mouse for 3D Imaging and Morphological Analysis
Related Videos
0 Views
12:24
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Related Videos
0 Views
04:01
Cannula Implantation into the Cisterna Magna in a Mouse Model
Related Videos
0 Views
01:59
Cre-LoxP Mediated Induction of Cerebral Cavernous Malformations in a Mouse Model
Related Videos
0 Views
02:05
Visualization of a Cerebral Thrombus in a Mouse Using Micro-Computed Tomography Imaging
Related Videos
0 Views
05:12
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Related Videos
0 Views
Last updated: 18 July 2026